MedPath

Diagnostic utility of Aspergillus IgG, IgA, and IgM for chronic pulmonary aspergillosis: systematic review and meta-analysis

Not Applicable
Conditions
chronic pulmonary aspergillosis
Registration Number
JPRN-UMIN000039838
Lead Sponsor
Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1) Comorbid advanced cancer 2) Using prednisolone-equivalent systemic steroid treatment of more than 10 mg/day for >3 weeks 3) Using immunosuppressive drugs or biologics (e.g. TNF inhibitor, IL-6 inhibitor, anti-CD20 monoclonal antibody, methotrexate, etc.) within the past 90 days. 4) inherited severe immunodeficiency 5) acquired immunodeficiency syndrome (AIDS)

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sensitivity and spedificity
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath